{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:01:45Z","timestamp":1761764505241,"version":"build-2065373602"},"reference-count":25,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,7,24]],"date-time":"2005-07-24T00:00:00Z","timestamp":1122163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2005,8]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To assess the clinical outcome of patients with a diagnosis of high\u2010grade prostatic intraepithelial neoplasia (PIN) on initial prostatic biopsy, with a minimum of 5\u2003years of follow\u2010up, as such patients are at greater risk of having prostate cancer on subsequent biopsy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS AND METHODS<\/jats:title>\n                    <jats:p>Between November 1992 and October 1998, 21 patients were identified as having PIN on their initial transrectal ultrasonography\u2010guided prostate biopsy. None of these patients had a focus of cancer on the initial biopsy. Their medical data were reviewed retrospectively to determine the natural history of PIN in these patients. Patients who were not identified as having cancer were followed every 6\u201312\u2003months with prostate\u2010specific antigen (PSA) testing and digital rectal examinations (DRE).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>A mean (range) of 7\u2003(2\u20138) cores were taken at initial biopsy; the mean age of the patients was 63 (53\u201377)\u2003years and mean PSA level 9.1\u2003(4.9\u201317.6)\u2003ng\/mL. Six patients had an abnormal DRE at presentation. A mean of 8 (7\u201310) cores were obtained on the second biopsy; six patients were diagnosed with cancer, with a mean Gleason score of 6\u2003(5\u20137), while three were diagnosed with persistent PIN. These three patients had a third prostate biopsy which showed cancer of Gleason score 6 in one and benign prostatic hyperplasia in two. After a mean follow\u2010up of 72.2\u2003 (60\u201384)\u2003months, none of the remaining 12 patients was diagnosed with clinically significant cancer. Five of these patients went on to a third prostate biopsy, with no evidence of cancer. One patient died from unrelated causes during this period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>This study affirms our current practice of following patients with PIN conservatively if a second or third subsequent prostate biopsy is negative. Whether PIN is a premalignant lesion or merely a lesion associated with cancer needs to be addressed in multicentre studies with a follow\u2010up of &gt;\u200a10\u2003years.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1464-410x.2005.05623.x","type":"journal-article","created":{"date-parts":[[2005,7,24]],"date-time":"2005-07-24T13:35:28Z","timestamp":1122212128000},"page":"320-323","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Do all patients with high\u2010grade prostatic intraepithelial neoplasia on initial prostatic biopsy eventually progress to clinical prostate cancer?"],"prefix":"10.1111","volume":"96","author":[{"given":"Jonathan I.","family":"Izawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iliana","family":"Lega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donal","family":"Downey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph L.","family":"Chin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick P.","family":"Luke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,7,24]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800053"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200108000-00014"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)66840-X"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)65881-6"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(02)01950-7"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2003.09.066"},{"key":"e_1_2_7_8_2","first-page":"2959","article-title":"Allelic loss on chromosome 8p12\u201321 in microdissected prostatic intraepithelial neoplasia","volume":"55","author":"Emmert\u2010Buck MR","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(00)00962-6"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0045(20000301)42:4<280::AID-PROS5>3.0.CO;2-P"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(20000415)86:2<155::AID-IJC2>3.0.CO;2-M"},{"key":"e_1_2_7_12_2","first-page":"557","article-title":"Preneoplastic lesions of the prostate \u2010 clinical, pathological and molecular biological aspects","volume":"16","author":"Nasir A","year":"2002","journal-title":"In Vivo"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-004-0041-7"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.240501205"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005392-199909010-00035"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540420041027"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64463-1"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(94)80015-4"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199601000-00010"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(99)90174-0"},{"key":"e_1_2_7_21_2","first-page":"1","article-title":"Finasteride effect on benign prostatic hyperplasia and prostate cancer. A comparative clinico\u2010pathologic study of radical prostatectomies","volume":"6","author":"Civantos F","year":"1997","journal-title":"J Urol Pathol"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(98)00579-2"},{"key":"e_1_2_7_23_2","first-page":"461","article-title":"Evaluation of prostatic intraepithelial neoplasia after treatment with 5\u2010alpha\u2010reductase inhibitor (finasteride). A methodologic approach","volume":"18","author":"Montironi R","year":"1996","journal-title":"Anal Quant Cytol Histol"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1159\/000019885"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0344-0338(11)80970-2"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199909000-00004"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-410X.2005.05623.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-410X.2005.05623.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T17:20:01Z","timestamp":1761758401000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-410X.2005.05623.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,24]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["10.1111\/j.1464-410X.2005.05623.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-410x.2005.05623.x","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"type":"print","value":"1464-4096"},{"type":"electronic","value":"1464-410X"}],"subject":[],"published":{"date-parts":[[2005,7,24]]},"assertion":[{"value":"2005-07-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}